Revance prices stock offering

Revance Therapeutics (RVNC) prices its public offering of 4M shares of common stock at $30.50/share. Underwriters over-allotment is 600K shares. Closing date is June 24.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs